Landos Biopharma, Inc.
NASDAQ:LABP
22.93 (USD) • At close May 23, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 37.549 | 36.64 | 8.305 | 2.416 | 9.808 | 0.359 |
| Short Term Investments
| 0 | 7.762 | 82.575 | 25.718 | 40.157 | 0 |
| Cash and Short Term Investments
| 37.549 | 44.402 | 90.88 | 28.134 | 49.965 | 0.359 |
| Net Receivables
| 0 | 0 | 0 | 0.154 | 0.001 | 2.092 |
| Inventory
| 0 | 0 | 0 | 1.398 | 0 | 0 |
| Other Current Assets
| 0.491 | 0.851 | 1.266 | 0.202 | 0.144 | 0.041 |
| Total Current Assets
| 38.04 | 45.253 | 92.146 | 29.888 | 50.11 | 2.492 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 0 | 0 | 0.707 | 0.444 | 0.359 | 0.304 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0 | 0 | 0.026 | 0 | 0.011 | 0 |
| Total Non-Current Assets
| 0 | 0 | 0.733 | 0.444 | 0.37 | 0.304 |
| Total Assets
| 38.04 | 45.253 | 92.879 | 30.332 | 50.48 | 2.796 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.375 | 3.435 | 12.908 | 8.606 | 2.048 | 1.692 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 4.874 | 2.687 | 3.703 | 2.428 | 0.978 | 0.104 |
| Total Current Liabilities
| 6.249 | 6.122 | 16.611 | 11.034 | 3.026 | 1.796 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 3.435 | 0 | 73.313 | 0 | 0 |
| Total Non-Current Liabilities
| 0 | 3.435 | 0 | 73.313 | 73.037 | 0 |
| Total Liabilities
| 6.249 | 6.122 | 16.611 | 84.347 | 76.063 | 1.796 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 92.879 | 73.037 | 73.037 | 0.032 |
| Common Stock
| 0.031 | 0.403 | 0.403 | 0.071 | 0.063 | 0.059 |
| Retained Earnings
| -155.362 | -133.427 | -94.151 | -55.729 | -25.585 | -9.135 |
| Accumulated Other Comprehensive Income/Loss
| 0 | -0.057 | -0.225 | 0.01 | -0.077 | 0 |
| Other Total Stockholders Equity
| 187.122 | 172.212 | 77.362 | -71.404 | -73.021 | 10.044 |
| Total Shareholders Equity
| 31.791 | 39.131 | 76.268 | -54.015 | -25.583 | 1 |
| Total Equity
| 31.791 | 39.131 | 76.268 | -54.015 | -25.583 | 1 |
| Total Liabilities & Shareholders Equity
| 38.04 | 45.253 | 92.879 | 30.332 | 50.48 | 2.796 |